4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000207
Director sold 8,000 shares at $73.49 ($587,920)
- Director acquired 8,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BERTHELSEN SPENCER R · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,000 | $24.42 | $195,360 | 164,013 | D |
| 2026-06-15 | Sale : show line 2 in the form 10b5-1 | −8,000 | $73.49 | $587,920 | 156,013 | D |
| Open-market sales · 8,000 sh · avg $73.49 · $587,920 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-15 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −8,000 | 0 | D |
Loading xslF345X06/edgardoc.xml…